The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
In Vitro Diagnostics Quality Control-Global Market Insights and Sales Trends 2024
Synopsis
In vitro diagnostics quality controls have taken on a crucial role in modern healthcare due to the better accuracy of diagnosis offered by their use.
The global In Vitro Diagnostics Quality Control market size is expected to reach US$ 732.9 million by 2029, growing at a CAGR of 3.1% from 2023 to 2029. The market is mainly driven by the significant applications of In Vitro Diagnostics Quality Control in various end use industries. The expanding demands from the Hospitals, Clinical Laboratories, Research and Academic Institutes and Others, are propelling In Vitro Diagnostics Quality Control market. Product, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Service segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for In Vitro Diagnostics Quality Control, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global In Vitro Diagnostics Quality Control market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global In Vitro Diagnostics Quality Control market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, In Vitro Diagnostics Quality Control sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of In Vitro Diagnostics Quality Control covered in this report include Abbott Laboratories, Bio-Rad, Helena Laboratories, Ortho Clinical Diagnostics, Randox Laboratories, Roche, Seracare, Siemens Healthineers and Sun Diagnostics, etc.
The global In Vitro Diagnostics Quality Control market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Bio-Rad
Helena Laboratories
Ortho Clinical Diagnostics
Randox Laboratories
Roche
Seracare
Siemens Healthineers
Sun Diagnostics
Thermo Fisher Scientific
Sysmex
Quantimetrix
Global In Vitro Diagnostics Quality Control market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global In Vitro Diagnostics Quality Control market, Segment by Type:
Product
Service
Global In Vitro Diagnostics Quality Control market, by Application
Hospitals
Clinical Laboratories
Research and Academic Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of In Vitro Diagnostics Quality Control companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
In vitro diagnostics quality controls have taken on a crucial role in modern healthcare due to the better accuracy of diagnosis offered by their use.
The global In Vitro Diagnostics Quality Control market size is expected to reach US$ 732.9 million by 2029, growing at a CAGR of 3.1% from 2023 to 2029. The market is mainly driven by the significant applications of In Vitro Diagnostics Quality Control in various end use industries. The expanding demands from the Hospitals, Clinical Laboratories, Research and Academic Institutes and Others, are propelling In Vitro Diagnostics Quality Control market. Product, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Service segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for In Vitro Diagnostics Quality Control, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global In Vitro Diagnostics Quality Control market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global In Vitro Diagnostics Quality Control market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, In Vitro Diagnostics Quality Control sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of In Vitro Diagnostics Quality Control covered in this report include Abbott Laboratories, Bio-Rad, Helena Laboratories, Ortho Clinical Diagnostics, Randox Laboratories, Roche, Seracare, Siemens Healthineers and Sun Diagnostics, etc.
The global In Vitro Diagnostics Quality Control market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Bio-Rad
Helena Laboratories
Ortho Clinical Diagnostics
Randox Laboratories
Roche
Seracare
Siemens Healthineers
Sun Diagnostics
Thermo Fisher Scientific
Sysmex
Quantimetrix
Global In Vitro Diagnostics Quality Control market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global In Vitro Diagnostics Quality Control market, Segment by Type:
Product
Service
Global In Vitro Diagnostics Quality Control market, by Application
Hospitals
Clinical Laboratories
Research and Academic Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of In Vitro Diagnostics Quality Control companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of In Vitro Diagnostics Quality Control
1.1 In Vitro Diagnostics Quality Control Market Overview
1.1.1 In Vitro Diagnostics Quality Control Product Scope
1.1.2 In Vitro Diagnostics Quality Control Market Status and Outlook
1.2 Global In Vitro Diagnostics Quality Control Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global In Vitro Diagnostics Quality Control Market Size by Region (2018-2029)
1.4 Global In Vitro Diagnostics Quality Control Historic Market Size by Region (2018-2023)
1.5 Global In Vitro Diagnostics Quality Control Market Size Forecast by Region (2024-2029)
1.6 Key Regions, In Vitro Diagnostics Quality Control Market Size (2018-2029)
1.6.1 North America In Vitro Diagnostics Quality Control Market Size (2018-2029)
1.6.2 Europe In Vitro Diagnostics Quality Control Market Size (2018-2029)
1.6.3 Asia-Pacific In Vitro Diagnostics Quality Control Market Size (2018-2029)
1.6.4 Latin America In Vitro Diagnostics Quality Control Market Size (2018-2029)
1.6.5 Middle East & Africa In Vitro Diagnostics Quality Control Market Size (2018-2029)
2 In Vitro Diagnostics Quality Control Market by Type
2.1 Introduction
2.1.1 Product
2.1.2 Service
2.2 Global In Vitro Diagnostics Quality Control Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global In Vitro Diagnostics Quality Control Historic Market Size by Type (2018-2023)
2.2.2 Global In Vitro Diagnostics Quality Control Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America In Vitro Diagnostics Quality Control Revenue Breakdown by Type (2018-2029)
2.3.2 Europe In Vitro Diagnostics Quality Control Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific In Vitro Diagnostics Quality Control Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America In Vitro Diagnostics Quality Control Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa In Vitro Diagnostics Quality Control Revenue Breakdown by Type (2018-2029)
3 In Vitro Diagnostics Quality Control Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinical Laboratories
3.1.3 Research and Academic Institutes
3.1.4 Others
3.2 Global In Vitro Diagnostics Quality Control Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global In Vitro Diagnostics Quality Control Historic Market Size by Application (2018-2023)
3.2.2 Global In Vitro Diagnostics Quality Control Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America In Vitro Diagnostics Quality Control Revenue Breakdown by Application (2018-2029)
3.3.2 Europe In Vitro Diagnostics Quality Control Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific In Vitro Diagnostics Quality Control Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America In Vitro Diagnostics Quality Control Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa In Vitro Diagnostics Quality Control Revenue Breakdown by Application (2018-2029)
4 In Vitro Diagnostics Quality Control Competition Analysis by Players
4.1 Global In Vitro Diagnostics Quality Control Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in In Vitro Diagnostics Quality Control as of 2022)
4.3 Date of Key Players Enter into In Vitro Diagnostics Quality Control Market
4.4 Global Top Players In Vitro Diagnostics Quality Control Headquarters and Area Served
4.5 Key Players In Vitro Diagnostics Quality Control Product Solution and Service
4.6 Competitive Status
4.6.1 In Vitro Diagnostics Quality Control Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories In Vitro Diagnostics Quality Control Products, Services and Solutions
5.1.4 Abbott Laboratories In Vitro Diagnostics Quality Control Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Bio-Rad
5.2.1 Bio-Rad Profile
5.2.2 Bio-Rad Main Business
5.2.3 Bio-Rad In Vitro Diagnostics Quality Control Products, Services and Solutions
5.2.4 Bio-Rad In Vitro Diagnostics Quality Control Revenue (US$ Million) & (2018-2023)
5.2.5 Bio-Rad Recent Developments
5.3 Helena Laboratories
5.3.1 Helena Laboratories Profile
5.3.2 Helena Laboratories Main Business
5.3.3 Helena Laboratories In Vitro Diagnostics Quality Control Products, Services and Solutions
5.3.4 Helena Laboratories In Vitro Diagnostics Quality Control Revenue (US$ Million) & (2018-2023)
5.3.5 Ortho Clinical Diagnostics Recent Developments
5.4 Ortho Clinical Diagnostics
5.4.1 Ortho Clinical Diagnostics Profile
5.4.2 Ortho Clinical Diagnostics Main Business
5.4.3 Ortho Clinical Diagnostics In Vitro Diagnostics Quality Control Products, Services and Solutions
5.4.4 Ortho Clinical Diagnostics In Vitro Diagnostics Quality Control Revenue (US$ Million) & (2018-2023)
5.4.5 Ortho Clinical Diagnostics Recent Developments
5.5 Randox Laboratories
5.5.1 Randox Laboratories Profile
5.5.2 Randox Laboratories Main Business
5.5.3 Randox Laboratories In Vitro Diagnostics Quality Control Products, Services and Solutions
5.5.4 Randox Laboratories In Vitro Diagnostics Quality Control Revenue (US$ Million) & (2018-2023)
5.5.5 Randox Laboratories Recent Developments
5.6 Roche
5.6.1 Roche Profile
5.6.2 Roche Main Business
5.6.3 Roche In Vitro Diagnostics Quality Control Products, Services and Solutions
5.6.4 Roche In Vitro Diagnostics Quality Control Revenue (US$ Million) & (2018-2023)
5.6.5 Roche Recent Developments
5.7 Seracare
5.7.1 Seracare Profile
5.7.2 Seracare Main Business
5.7.3 Seracare In Vitro Diagnostics Quality Control Products, Services and Solutions
5.7.4 Seracare In Vitro Diagnostics Quality Control Revenue (US$ Million) & (2018-2023)
5.7.5 Seracare Recent Developments
5.8 Siemens Healthineers
5.8.1 Siemens Healthineers Profile
5.8.2 Siemens Healthineers Main Business
5.8.3 Siemens Healthineers In Vitro Diagnostics Quality Control Products, Services and Solutions
5.8.4 Siemens Healthineers In Vitro Diagnostics Quality Control Revenue (US$ Million) & (2018-2023)
5.8.5 Siemens Healthineers Recent Developments
5.9 Sun Diagnostics
5.9.1 Sun Diagnostics Profile
5.9.2 Sun Diagnostics Main Business
5.9.3 Sun Diagnostics In Vitro Diagnostics Quality Control Products, Services and Solutions
5.9.4 Sun Diagnostics In Vitro Diagnostics Quality Control Revenue (US$ Million) & (2018-2023)
5.9.5 Sun Diagnostics Recent Developments
5.10 Thermo Fisher Scientific
5.10.1 Thermo Fisher Scientific Profile
5.10.2 Thermo Fisher Scientific Main Business
5.10.3 Thermo Fisher Scientific In Vitro Diagnostics Quality Control Products, Services and Solutions
5.10.4 Thermo Fisher Scientific In Vitro Diagnostics Quality Control Revenue (US$ Million) & (2018-2023)
5.10.5 Thermo Fisher Scientific Recent Developments
5.11 Sysmex
5.11.1 Sysmex Profile
5.11.2 Sysmex Main Business
5.11.3 Sysmex In Vitro Diagnostics Quality Control Products, Services and Solutions
5.11.4 Sysmex In Vitro Diagnostics Quality Control Revenue (US$ Million) & (2018-2023)
5.11.5 Sysmex Recent Developments
5.12 Quantimetrix
5.12.1 Quantimetrix Profile
5.12.2 Quantimetrix Main Business
5.12.3 Quantimetrix In Vitro Diagnostics Quality Control Products, Services and Solutions
5.12.4 Quantimetrix In Vitro Diagnostics Quality Control Revenue (US$ Million) & (2018-2023)
5.12.5 Quantimetrix Recent Developments
6 North America
6.1 North America In Vitro Diagnostics Quality Control Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe In Vitro Diagnostics Quality Control Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Diagnostics Quality Control Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America In Vitro Diagnostics Quality Control Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Diagnostics Quality Control Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 In Vitro Diagnostics Quality Control Market Dynamics
11.1 In Vitro Diagnostics Quality Control Industry Trends
11.2 In Vitro Diagnostics Quality Control Market Drivers
11.3 In Vitro Diagnostics Quality Control Market Challenges
11.4 In Vitro Diagnostics Quality Control Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
